Paxlovid Drug-Drug Interactions COVID-19 Treatment Guidelines

paxlovid  Update for pharmacists: 11 April 2024 Paxlovid , with the batch number GJ2963 expired on 31 March 2024  The antiviral Paxlovid is very effective at preventing severe outcomes from COVID infection, but not enough people are taking it

Paxlovid is an oral coronavirus medicine used in outpatient treatment for people aged 18 or over and at risk of developing the severe form of COVID-19 due to Standard dosing: PAXLOVID Tablets 300 mg; 100 mg Dose Pack

Paxlovid is an oral antiviral drug that should be initiated as soon as possible within 5 days of symptom onset  COVID-19 oral antiviral treatments Paxlovid and Lagevrio are available on the commercial market Patient assistance programs are available